• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于实验室的实用临床决策工具与短期出血和死亡率结局的关联。

Practical laboratory-based clinical decision tools and associations with short-term bleeding and mortality outcomes.

机构信息

Intermountain Heart Institute, Intermountain Medical Center, 5121 S Cottonwood St, Salt Lake City, UT, USA.

Intermountain Heart Institute, Intermountain Medical Center, 5121 S Cottonwood St, Salt Lake City, UT, USA; Cardiology Division, Department of Internal Medicine, University of Utah, 30 N 1900 E, Salt Lake City, UT, USA.

出版信息

Clin Chim Acta. 2018 Jul;482:166-171. doi: 10.1016/j.cca.2018.04.006. Epub 2018 Apr 6.

DOI:10.1016/j.cca.2018.04.006
PMID:29627489
Abstract

BACKGROUND

The red cell distribution width (RDW) predicts mortality in numerous populations. The Intermountain Risk Scores (IMRS) predict patient outcomes using laboratory measurements including RDW. Whether the RDW or IMRS predicts in-hospital outcomes is unknown.

METHODS

The predictive abilities of RDW and two IMRS formulations (the complete blood count [CBC] risk score [CBC-RS] or full IMRS using CBC plus the basic metabolic profile) were studied among percutaneous coronary intervention patients at Intermountain (males: N = 6007, females: N = 2165). Primary endpoints were a composite bleeding outcome and in-hospital mortality.

RESULTS

IMRS predicted the composite bleeding endpoint (females: χ = 47.1, odds ratio [OR] = 1.13 per +1 score, p < 0.001; males: χ = 108.7, OR = 1.13 per +1 score, p < 0.001) more strongly than RDW (females: χ = 1.6, OR = 1.04 per +1%, p = 0.20; males: χ = 11.2, OR = 1.09 per +1%, p < 0.001). For in-hospital mortality, RDW was predictive in females (χ = 4.3, OR = 1.13 per +1%, p = 0.037) and males (χ = 4.4, OR = 1.11 per +1%, p = 0.037), but IMRS was profoundly more predictive (females: χ = 35.5, OR = 1.36 per +1 score, p < 0.001; males: χ = 72.9, OR = 1.40 per+1 score, p < 0.001). CBC-RS was more predictive than RDW but not as powerful as IMRS.

CONCLUSIONS

The IMRS, the CBC-RS, and RDW predict in-hospital outcomes. Risk score-directed personalization of in-hospital clinical care should be studied.

摘要

背景

红细胞分布宽度(RDW)可预测众多人群的死亡率。 山间风险评分(IMRS)使用包括 RDW 在内的实验室测量值来预测患者的预后。RDW 或 IMRS 哪个可以预测住院期间的结局尚不清楚。

方法

研究了山间地区经皮冠状动脉介入治疗患者的 RDW 和两种 IMRS 公式(全血细胞计数[CBC]风险评分[CBC-RS]或使用 CBC 加基本代谢谱的完整 IMRS)的预测能力(男性:N=6007,女性:N=2165)。主要终点是复合出血结局和住院死亡率。

结果

IMRS 比 RDW 更能预测复合出血终点(女性:χ=47.1,优势比[OR]每增加 1 分则为 1.13,p<0.001;男性:χ=108.7,OR 每增加 1 分则为 1.13,p<0.001)(女性:χ=1.6,OR 每增加 1%则为 1.04,p=0.20;男性:χ=11.2,OR 每增加 1%则为 1.09,p<0.001)。对于住院死亡率,RDW 在女性(χ=4.3,OR 每增加 1%则为 1.13,p=0.037)和男性(χ=4.4,OR 每增加 1%则为 1.11,p=0.037)中具有预测性,但 IMRS 的预测性更强(女性:χ=35.5,OR 每增加 1 分则为 1.36,p<0.001;男性:χ=72.9,OR 每增加 1 分则为 1.40,p<0.001)。CBC-RS 比 RDW 更具预测性,但不如 IMRS 强大。

结论

IMRS、CBC-RS 和 RDW 均可预测住院期间的结局。应研究基于风险评分的住院期间临床护理的个性化治疗。

相似文献

1
Practical laboratory-based clinical decision tools and associations with short-term bleeding and mortality outcomes.基于实验室的实用临床决策工具与短期出血和死亡率结局的关联。
Clin Chim Acta. 2018 Jul;482:166-171. doi: 10.1016/j.cca.2018.04.006. Epub 2018 Apr 6.
2
Pulmonary-Specific Intermountain Risk Score Predicts All-Cause Mortality via Spirometry, the Red Cell Distribution Width, and Other Laboratory Parameters.肺特异性山间风险评分通过肺活量测定、红细胞分布宽度和其他实验室参数预测全因死亡率。
Respir Care. 2015 Sep;60(9):1314-23. doi: 10.4187/respcare.03370. Epub 2015 Apr 14.
3
Complete blood count risk score and its components, including RDW, are associated with mortality in the JUPITER trial.在JUPITER试验中,全血细胞计数风险评分及其组成部分,包括红细胞分布宽度(RDW),与死亡率相关。
Eur J Prev Cardiol. 2015 Apr;22(4):519-26. doi: 10.1177/2047487313519347. Epub 2014 Jan 8.
4
Improvement in the predictive ability of the Intermountain Mortality Risk Score by adding routinely collected laboratory tests such as albumin, bilirubin, and white cell differential count.通过添加常规收集的实验室检查项目(如白蛋白、胆红素和白细胞分类计数)来提高山间死亡率风险评分的预测能力。
Clin Chem Lab Med. 2016 Oct 1;54(10):1619-28. doi: 10.1515/cclm-2015-1258.
5
Red cell distribution width is predictive of mortality in trauma patients.红细胞分布宽度可预测创伤患者的死亡率。
J Trauma Acute Care Surg. 2013 Apr;74(4):1021-6. doi: 10.1097/TA.0b013e3182826f02.
6
Comparative evaluation of the clinical laboratory-based Intermountain risk score with the Charlson and Elixhauser comorbidity indices for mortality prediction.临床实验室为基础的 Intermountain 风险评分与 Charlson 和 Elixhauser 合并症指数对死亡率预测的比较评估。
PLoS One. 2020 May 21;15(5):e0233495. doi: 10.1371/journal.pone.0233495. eCollection 2020.
7
Repeated measurement of the intermountain risk score enhances prognostication for mortality.重复测量山间风险评分可提高死亡率的预后预测。
PLoS One. 2013 Jul 17;8(7):e69160. doi: 10.1371/journal.pone.0069160. Print 2013.
8
Association of the dispersion in red blood cell volume with mortality.红细胞体积离散度与死亡率的关联。
Eur J Clin Invest. 2015 Jun;45(6):541-9. doi: 10.1111/eci.12432. Epub 2015 May 13.
9
The Intermountain Risk Score (including the red cell distribution width) predicts heart failure and other morbidity endpoints.Intermountain 风险评分(包括红细胞分布宽度)可预测心力衰竭和其他发病率终点。
Eur J Heart Fail. 2010 Nov;12(11):1203-13. doi: 10.1093/eurjhf/hfq115. Epub 2010 Aug 12.
10
Validation of the Intermountain Risk Score and Get with the Guidelines-Heart Failure Score in predicting mortality.验证 Intermountain 风险评分和 Get with the Guidelines-Heart Failure 评分对死亡率的预测能力。
Open Heart. 2021 Aug;8(2). doi: 10.1136/openhrt-2021-001722.